We have moved to new location, Please click on contact us  
Home  >  News
Eppen_Conical_Feb2023
you can get e-magazine links on WhatsApp. Click here
Pharma People + Font Resize -

Kappa Bioscience expands K2VITAL® K2-7 presencein South Asia with appointment of Hidayat Ali

Our Bureau, Mumbai
Thursday, June 4, 2020, 11:30 Hrs  [IST]

Kappa Bioscience AS, apioneer in development and production of synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL® brand name, has announced the appointment of Hidayat Ali as Kappa Head of Business Development, South Asia. The position was created in response to rapid regional growth, particularly for Kappa’s microencapsulated K2VITAL® DELTA product.

Vitamin K2 is an essential vitamin which helps balance calcium in the body. It is a frequent prescription for osteoporosis in India because it activates the protein which incorporates calcium into bone. K2 is frequently included in bone health formulations that include calcium or other mineral salts. Market studies, however, demonstrate that unprotected K2-7 is not stable with mineral salts and degrades. Kappa’s DELTA product is the only microencapsulated K2-7 with drug approval and import license to India.

Hidayat Ali will be based in Mumbai. Prior to joining Kappa, he held a position for SEKISUI Chemical Co. Ltd, Japan where he oversaw growth of the synthetic amino acid for nearly a decade. His deep experience in the industry also includes positions with Indian companies such as Associated Capsules Pvt Ltd and RusanPharma Ltd. HidayatAli will work alongside S.A. Pharmachem, Pvt Ltd, Kappa’s long-standing K2VITAL® distributor in India and other partners within the South Asian region.

“We were delighted to secure a relationship with Hidayat Ali as part of our campaign to expand the footprint of K2VITAL® in important South Asian markets,’’ commented EgilGreve, CEO of Kappa Bioscience. He continued, ‘’Kappa has invested significantly in the DELTA drug approval process to better serve the needs of India’s large and aging population. We’re confident the appointment will expand our growing presence and create new opportunity for Indian brands and marketers.’’

K2VITAL® promotes bone and heart health by activating two proteins which balance calcium in the body. K2 is an essential vitamin and is required in all stages of life. Vitamin K2 provides synergistic benefits to calcium, magnesium, and omega-3 in a formulation and is the 'Perfect Pair' complement to vitamin D3. Kappa’s microencapsulated K2VITAL® DELTA is the market leader in formulations that include minerals where K2 stability is an issue.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
India Lab Expo
Pharma_Live_Expo_2023
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |